Other assets consisted of the following (in thousands): | | | | | | | | | | | | | August 31, 2026 | | November 30, 2025 | | Cash surrender value of corporate-owned life insurance contracts | $ | 48,905 | | | $ | 51,182 | | | Lease right-of-use assets | 28,040 | | | 17,494 | | | Prepaid expenses | 21,857 | | | 14,982 | | Other (a) | 7,629 | | | 24,175 | | | Total | $ | 106,431 | | | $ | 107,833 | |
(a) Included a $15.2 million investment in equity securities of a privately held technology company without a readily determinable fair value at November 30, 2025. On August 21, 2026, we sold this investment for cash proceeds of $20.0 million and recognized a gain of $3.5 million, which is included in interest income and other in our consolidated statements of operations for the three months and nine months ended August 31, 2026. Certain of our executives, including our executive chairman of the board, are entitled to a portion of the sale proceeds pursuant to ownership interests they acquired, through an incentive program, in the limited liability company that held the investment, as described in the Proxy Statement for our 2025 Annual Meeting of Stockholders.
|